Zhejiang Huahai Pharmaceutical Co., Ltd.
EIR issued August 21, 2018 · Linhai, China
- Inspection
- Jul 23 – Aug 3, 2018
- Investigators
- Cheryl Clausen· Joel D. Hustedt
- Pages
- 58
- FEI number
- 3003885745
In short: This is FDA's Establishment Inspection Report (EIR) for Zhejiang Huahai Pharmaceutical Co., Ltd. in Linhai, Zhejiang (FEI 3003885745), covering the inspection of Jul 23 – Aug 3, 2018. It is the investigator's full narrative of what they examined, who they spoke to and what they found. The investigators were Cheryl Clausen and Joel D. Hustedt.
Inside this inspection report
The investigator's narrative
The full inspection report: what the investigator looked at, who they spoke to and what they found, in their own words.
Get the full EIRThis inspection in context
Cheryl Clausen
18 documents · 2016–2020
Cites 211.22 (responsibilities of quality control unit) more than any other section. Most of their documents are for sites in India.
The firmZhejiang Huahai Pharmaceutical Co., Ltd. history
All 5 documents on file for this site, in date order, with what was cited at each inspection.
Similar documentsMore eirs
Browse other documents of this type.
Questions about this EIR
Who inspected Zhejiang Huahai Pharmaceutical Co., Ltd.?
Cheryl Clausen and Joel D. Hustedt are named on this EIR, for the inspection of Jul 23 – Aug 3, 2018. Each investigator has a profile showing what they cite most.
When was Zhejiang Huahai Pharmaceutical Co., Ltd. inspected by FDA?
The inspection ran Jul 23 – Aug 3, 2018.
How do I get the full EIR for Zhejiang Huahai Pharmaceutical Co., Ltd.?
Download the original PDF from FDA Intel for $550, with no subscription. You also get an invoice PDF with the order.